Maze Therapeutics (MAZE) Stock Price & Analysis
MAZE$33.90-0.43 -1.25%
Market cap$1.85BEnterprise value$1.96BRevenue (TTM)$20.00MMarket position—
Score
64
Neutral
Value
56
Quality
37
Growth
100
AI Analysis
SnapshotMaze Therapeutics doesn’t screen as a clean setup today — Stocklytics 64/100 leaves more to prove. Under the hood: revenue compounding ~-100% annually over recent years.
Price History
Price: —
Fair value: —
—
P/E (TTM): —
Net Income (TTM): —
Score: —
—
Bullish (65+)Neutral (45–64)Bearish (<45)
Score Breakdown
Market percentile scores loading…
Value
56
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–
Growth
100
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–
Quality
37
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–
Financial Summary
Maze Therapeutics, Inc. (MAZE) last printed $33.90. Equity value is $1.85B. Trailing earnings multiple —. The revenue row is reported history. Targets and ratings are on the forecast page.
Financials
| 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|
| $0.00 | $0.00 | $167.5M | $0.00 |
About
Company description is not on file.